How biology emerged in history
• Stemerding D. & Hilgartner S.
(1998a) Means of coordination in making biological science: on the mapping of plants, animals and genes. In: C. Disco, B. van der Meulen (eds.), Getting New Technologies Together. Studies in making sociotechnical order. Berlijn: de Gruyter, 39-69.
• Stemerding D.
(1993a)
How to make oneself nature’s spokesman? A Latourian account of classification in eighteenth- and early nineteenth natural history, Biology & Philosophy 8, 193-223.
• Stemerding D.
(1991) Plants, Animals and Formulae. Natural History in the Light of Latour’s Science in Action and Foucault’s The Order of Things, Delft: Eburon (PhD dissertation).
• Stemerding D.
(1989) Latour’s antropologie van de wetenschap. Planten, dieren en formules - classificaties in de achttiende eeuw. In: L. Boon & G.H. de Vries (red.) Wetenschapstheorie. De empirische wending. Groningen: Wolters-Noordhoff, 72-84.
Public and political engagement in biotechnology
• Stemerding, D. & Asveld, L.
(2016a) Industrial biotechnology under the spotlights. Den Haag: Rathenau Instituut. • Asveld, L. & Stemerding, D.
(2016b) Algae oil on trial: Conflicting views of technology and nature. Den Haag: Rathenau Instituut. • Munnichs, G. M., de Vriend, H. J. & Stemerding, D.
(2016c) Afwegingskader nationale teeltbevoegdheid gg-gewassen: Verslag van een stakeholderdialoog. Den Haag: Rathenau Instituut.
• Asveld, L., van Est, R. & Stemerding, D.
(eds.) (2011a) Naar de kern van de bio-economie. De duurzame beloftes van biomassa in perspectief. Den Haag: Rathenau Instituut.
• Asveld, L., van Est, R. & Stemerding, D.
(eds.) (2011b) Getting to the Core of the Bio-economy: A Perspective on the Sustainable Promise of Biomass. Den Haag: Rathenau Instituut.
• Vriend, H.J. de & Stemerding, D.
(2011c) Innovatie: op weg naar een bio-economie? In: L. Asveld, R. van Est & D. Stemerding (eds.) Naar de kern van de bio-economie. De duurzame beloftes van biomassa in perspectief. Den Haag: Rathenau Instituut.
• Vriend, H.J. de & Stemerding, D.
(2011d) Innovation: en route to a bio-economy? In: L. Asveld, R. van Est & D. Stemerding (eds.) Getting to the Core of the Bio-economy: A Perspective on the Sustainable Promise of Biomass. Den Haag: Rathenau Instituut, 89-125.
• Stemerding, D., Murdock, K., van der Meulen, B. & Brom, F.W.A.
(2011e) Implementing Biosecurity in (Bio-)scientific Research in the Netherlands: Policy Brief. Den Haag: Rathenau Instituut, 85-120.
• Asveld, L., van Est, R. & Stemerding, D.
(2010a) Biobased Economy: global chance or threat? Den Haag: Rathenau Instituut.
• Mampuys, R., Stemerding, D. & van der Meulen, B. (2009a) Doelstellingen van dierproeven gewogen en te licht bevonden? In: J. Swart, M. Jonker & R. Tramper (red.) De Weging Gewogen. Beschouwingen over Ethiek en Dierproeven. Budel: Damon, 95-105.
• Stemerding, D. & Jelsma, J.
(2003) Dutch roads to a socially acceptable gene technology. International Journal of Biotechnology 5(1), 47-57.
Genetics, genomics and health care
• Krom, A., Almeida, M., Hennen, L., Leichteris, E., Sauter, A. & Stemerding, D.
(2016d) The future panel on public health genomics: Lessons learned and future perspectives. In: Klüver, L., Nielsen, R. O. & Jorgensen, M. L. (eds.) Policy-oriented technology assessment across Europe: Expanding capacities. Hampshire UK: Palgrave Macmillan, 90-104
• Stemerding, D. & Krom, A.
(eds.) (2014a) Policy Brief on Public Health Genomics. The Hague: Rathenau Instituut.
• Stemerding, D. & Nahuis, R.
(2014b) Implicit and explicit notions of valorization in genomics research, New Genetics and Society 33(1): 79-95.
• Stemerding, D. & Krom, A.
(eds.) (2013a) Expert paper for the Future Panel on Public Health Genomics. The Hague: Rathenau Instituut.
• Nahuis, R. & Stemerding, D.
(2013b) Genomics as a new research regime? Evidence from the Netherlands, Research Policy 42(3): 676-687.
• Bitsch, L. & Stemerding, D.
(2013c) The innovation journey of genomics and asthma research. Sociology of Health and Illness 35(8): 1164-1180.
• Stemerding, D.
(2010b) Community genetics: 1998 – 2009 … and beyond. Journal of Community Genetics 1: 195-199.
• Geesink, I., Messer, P. & Stemerding, D.
(2008a) Consument wordt baas over eigen genen. Een gentest die de kans op tientallen ziekten meldt als cadeau onder de kerstboom. Een nieuwe groeimarkt. Financieel Dagblad, 15 december.
• Stemerding, D., van Rijswoud, E. & Swinkels, E.W.
(2008b) Zelftestests: zelfbeschikking of professionele bescherming? Nederlands Tijdschrift voor Klinische Chemie en Labgeneeskunde 33: 35-38.
• Rijswoud, E., Stemerding, D. & Swierstra, T.E.
(2008c) Genetica, Genomics en Gezondheidszorg, Nijmegen: Centre for Society and Genomics, Radboud Universiteit.
• Stemerding, D. & Nelis, A.P.
(2006a) Cancer genetics and its ‘different faces of autonomy’. New Genetics & Society 25(1): 1-19.
• Stemerding, D. & Nelis, A.P.
(2005a) Choices and choosing in cancer genetics. In: H Harbers (ed.) Inside the Politics of Technology: Agency and Normativity in the Co-Production of Technology and Society, Amsterdam University Press, 109-124.
• Stemerding D. & Nelis, A.P.
(2004) New practices of screening in the field of cancer genetics: a co-evolutionary perspective. In: P Glasner (ed.) Reconfigurating Nature. Issues and Debates in the New Genetics. London: Ashgate, 203-222.
• Bourret, P., Koch, L. & Stemerding D.
(1998b) DNA diagnosis and the emergence of cancer-genetic services in European health care. In: P. Wheale, R. von Schomberg & P. Glasner (eds.) The Social Management of Genetic Engineering. London: Ashgate, 117 -138.
• Stemerding D., Koch L. & Bourret P.
(1997) DNA-diagnosis and the emergence of cancer-genetic services in European health care, European Journal of Human Genetics 5 (suppl. 2): 25-30.
• Stemerding D.
(1995) The entrenchment of human genome technology in society: on shifting boundaries between private and public discourses. In: R. von Schomberg (ed.) Contested Technology. Ethics, Risk and Public Debate. Tilburg: International Centre for Human and Public Affairs,143-154.
• Koch L. & Stemerding D.
(1994) The sociology of entrenchment: a cystic fibrosis test for everyone? Social Science & Medicine 39(9): 1211-1220. • Stemerding D.
(1993b) How to deal with the implications of human genome research? On the bounds of a politics of regulation. In: H. Haker, R. Hearn & K. Steigleder (eds.) Ethics of Human Genome Analysis. European Perspectives. Tübingen: Attempto Verlag, 217-235.
Screening for a healthy fetus
• Meijer, S., Stemerding, D., Hoppe, R., Schielen, P. & Loeber, G.
(2010c) Prenatale screening: een (on)getemd maatschappelijk probleem? TSG 88: 454-460.
• Achterbergh, R., Lakeman, Ph., Stemerding, D., Moors, E.H.M. & Cornel, M.C.
(2007) Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: A sociotechnical analysis, Health Policy 83: 277-286.
• Linden, C.S. van der & Stemerding, D.
(2006b) Heeft niet-invasieve prenatale diagnostiek de toekomst? Tijdschrift voor Verloskundigen 31(11): 23-27.
• Stemerding, D. & van Berkel, D. (2001) Maternal serumscreening, political descision-making and social learning. Health Policy 56: 111-125.
• Berkel D. van & Stemerding D.
(1999) Maternale serumscreening, politieke besluitvorming en de rol van maatschappelijke leerprocessen, Tijdschrift voor Gezondheidswetenschappen 77(4): 225-234.
Technology and future making
• Est, R. van & Stemerding, D.
(eds.) (2012a) Making Perfect Life. European Governance Challenges in 21st Century Bio-engineering: Final Study. Brussels: STOA.
• Est, R. van & Stemerding, D.
(eds.) (2012b) Making Perfect Life. European Governance Challenges in 21st Century Bio-engineering: Extended Briefing Note. Brussels: STOA.
• Est, R. van & Stemerding, D.
(eds.) (2012c) Making Perfect Life. European Governance Challenges in 21st Century Bio-engineering: Options Brief. Brussels: STOA.
• Est, R. van & Stemerding, D.
(eds.) (2011f) Making Perfect Life. Bio-engineering (in) the 21st Century: Monitoring Report. Brussels: STOA.
• Mampuys, R. & Stemerding, D.
(2010c) Mondiale Motivatie of Europese Eigenheid? Vier scenario's voor ggo's in de Europese Landbouw. Bilthoven: Commissie Genetische Modificatie & Rathenau Instituut.
• Mampuys, R. & Stemerding, D.
(2010d) Global Motivation or European Character? Four Scenarios for GMOs in European Agriculture. Bilthoven: Commissie Genetische Modificatie & Rathenau Instituut.
• Stemerding, D., Swierstra, T.E. & Boenink, M.
(2010e) Exploring the interaction between technology and morality in the field of genetic susceptibility testing: a scenario study. Futures 42: 1133-1145.
• Boenink, M., Swierstra, T.E. & Stemerding, D.
(2010f) Anticipating the interaction between technology and morality: a techno-ethical scenario study of experimenting with humans in bio-nanotechnology. Studies in Ethics, Law and Technology 4(2), 1-38.
• Swierstra, T.E., Stemerding, D. & Boenink, M.
(2009b) Exploring techno-moral change. The case of the Obesity Pill. In: P. Sollie & M. Düwel (eds.) Evaluating New Technologies. Methodological Problems for the Ethical Assessment of Technology Developments. Berlin: Springer, 119-138.
• Stemerding, D. & Swierstra, T.E.
(2006b) How might scenariostudies help us to think about the normative implications of genomics and predictive medicine? In: A. de Bouvet, P. Boitte & G. Aiguier (eds.) Questions éthiques en médicine predictive. John Libbey Eurotext, 81-88.
A new engineering science of life
• Rerimassie, V., Stemerding, D., Zhang, W. & Srinivas, K. R.
(2015a) Discourses on Synthetic Biology in Europe. In: Ladikas, M., Chaturvedi, S., Zhao, Y. & Stemerding, D. (eds.) Science and Technology Governance and Ethics: A Global Perspective from Europe, India and China. Springer, 145-163.
• Stemerding, D. & Jochemsen, H.
(2014c) Niet natuurlijk? In: Hoekstra, W., van Maris, T., Poolman, B., Pronk, J. & Buiter, R. (eds.) Synthetische Biologie: Creatief met Cellen. Den Haag: Stichting Biowetenschappen en Maatschappij Vol. 33, 56-57.
• Rerimassie, V. & Stemerding, D.
(2014d) Verantwoord verder. In: Hoekstra, W., van Maris, T., Poolman, B., Pronk, J. & Buiter, R. (eds.) Synthetische Biologie: Creatief met Cellen. Stichting Biowetenschappen en Maatschappij Vol. 33, 59-67.
• Rerimassie, V. & Stemerding, D.
(2014e) SynBio Politics: Bringing synthetic biology into debate. Den Haag: Rathenau Instituut.
• Stemerding, D. & Douglas, C.
(2014f) Challenges for the European governance of synthetic biology for human health, Life Sciences, Society and Policy 10(6).
• Douglas, C. & Stemerding, D.
(2013d) Special issue editorial: synthetic biology, global health and global Den governance. Systems and Synthetic Biology 7 (3): 63-66.
• Douglas, C. & Stemerding, D.
(2013e) Governing synthetic biology for global health through responsible research and innovation. Systems and Synthetic Biology 7 (3): 139-150.
• Rerimassie, V. & Stemerding, D.
(2013f) Politiek over Leven. In Debat over Synthetische Biologie. Den Haag: Rathenau Instituut.
• Stemerding, D. & van Est, R. (red.) (2013g) Geen Debat Zonder Publiek. Het Opkomende Debat over Synthetische Biologie Ontleed. Den Haag: Rathenau Instituut.
• Stemerding, D. & Rerimassie, V.
(2013h Discourses on synthetic biology in Europe. Den Haag: Rathenau Instituut.
• Evers, J., Hennen, L., Kertess, L., Sauter, A., Stemerding, D., Tennoe, T. & Torgesen, H.
(2011g) Synthetic Biology. Berlin: EPTA Briefing note.
• Stemerding, D., de Vriend, H., Walhout, B. & van Est, R. (2009c) Synthetic biology and the role of civil society organizations. Shaping the agenda and arena of the public debate. In: M. Schmidt, A. Kelle, A. Ganguli, H. de Vriend (eds.) Synthetic Biology. The Techno-science and its Societal Consequences. Springer Academic Publishing, chapter 10.
Technology assessment, ethics and regulation
• Stemerding, D. & de Vriend, H.
(2018) Nieuwe risico’s, nieuwe aanpak, Tijdschrift Milieu 24(1): 10-11.
• Stemerding, D.
(2017) NBIC convergence as a challenge for bioethics and biopolitics. In: L. Caenazzo, L. Mariani & R. Pegoraro (eds.) Convergence of New Emerging Technologies. Ethical challenges and new responsibilities. Piccin: Padova, Italy, 23-62.
• Est, R. van, Timmer, J., Kool, L., Nijsingh, N., Rerimassie, V. & Stemerding, D.
(2016e) Rules for the digital human park: Two paradigmatic cases of breeding and taming human beings - Human germline editing and persuasive technology. Background paper for the 11th Global Summit of National Ethics/Bioethics Committees.
• Rerimassie, V., Stemerding, D., de Bakker, E. & van Est, R.
(2016f) Van draagvlak naar meer: Ontwerp van een maatschappelijke incubator voor beloftevolle (nano)technologieën. Den Haag: Rathenau Instituut (Design of 'societal incubator' for new technologies, report includes an extended summary in English).
• Stemerding, D.
(2015b)
Van bio-ethiek naar biopolitiek: Uitdagingen van NBIC convergentie voor de bio-ethiek. Utrecht: Nederlandse Vereniging voor Bio-ethiek (Preadvies).
• Ladikas, M., Chaturvedi, S., Zhao, Y. & Stemerding, D.
(eds.) (2015c) Science and Technology Governance and Ethics: A Global Perspective from Europe, India and China. Springer.
• Stemerding, D., Rerimassie, V., van Est, R., Zhao, Y., Chaturvedi, S., Ladikas, M. & Brom, F.W.A.
(2015d) A Comparative Framework for Studying Global Ethics in Science and Technology. In: Ladikas, M., Chaturvedi, S., Zhao, Y. & Stemerding, D. (eds.) Science and Technology Governance and Ethics: A Global Perspective from Europe, India and China. Springer, 99-110.
• Stemerding, D. & Krom, A.
(2015e) Advanced genomics in health care? Using technology assessment to design a step-by-step approach in EU member states. In: Scherz, C., Michalek, T., Hennen, L., Habakova, L., Hahn, J. & Seitz, S. B. (eds.) The next horizon of technology assessment: Proceedings from the PACITA 2015 Conference in Berlin. Prague, 193-198.
• Est, R. van, Stemerding, D., Rerimassie, V., Schuijff, M., Timmer, J. & Brom, F. W. A.
(2014g) From Bio to NBIC convergence: From medical practice to daily life. Report written for the Council of Europe, Committee on Bioethics, Den Haag: Rathenau Instituut.
• Est, R.van & Stemerding, D.
(2013i) Governance strategies for living technologies: Bridging the gap between stimulating and regulating techno-science. Artificial Life 19(3-4): 437-450.
• Est, R. van, Walhout, B., Rerimassie, V., Stemerding, D. & Hanssen, L.
(2012d) Governance of nanotechnology in the Netherlands - informing and engaging in different social spheres. International Journal of Emerging Technologies and Society 10, 6-26.
• Baarda, M., Jones, V. & Stemerding, D.
(2005b) BAN-based M-health services: experiences and prospects. Proceedings 4th International Conference on the Management of Healthcare & Medical Technology, Denmark: Aalborg, 25-26 August.
Responsible research and innovation
• Stemerding, D., Betten, A.W., Rerimassie, V., Robaey, Z.H. & Kupper, F.
(forthcoming) Future making and responsible governance of innovation in synthetic biology, Futures.
• Stemerding, D.
(forthcoming) From technology assessment to responsible innovation in synthetic biology. In: von Schomberg, R. (ed.) Handbook - Responsible Innovation: A Global Resource. Edward Elgar Publishing Ltd.
• Stemerding, D.
(2015f) iGEM as laboratory in responsible research and innovation, Journal of Responsible Innovation 2(1): 140-142.